Answer
Whether brodalumab passes into human milk is unknown, but it is expected in the first milk and at low levels afterwards; risk to infants cannot be excluded, so stopping breast-feeding or Kyntheum therapy requires weighing benefits for mother and child.
Sources for this answer
- Kyntheum 210 mg Solution for InjectionLeo Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked